HC Wainwright & Co. analyst Douglas Tsao maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $105 to $120.
HC Wainwright & Co. Maintains Buy on Praxis Precision Medicine, Raises Price Target to $120
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.